{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:47:10Z","timestamp":1773283630197,"version":"3.50.1"},"reference-count":170,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T00:00:00Z","timestamp":1490054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T00:00:00Z","timestamp":1490054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000943","name":"Commonwealth Scientific and Industrial Research Organisation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000943","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001781","name":"Swinburne University of Technology","doi-asserted-by":"publisher","award":["ARC Training Centre for Biodevices"],"award-info":[{"award-number":["ARC Training Centre for Biodevices"]}],"id":[{"id":"10.13039\/501100001781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Top Curr Chem (Z)"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s41061-017-0127-6","type":"journal-article","created":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T16:12:19Z","timestamp":1490112739000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Polymers in the Delivery of siRNA for the Treatment of Virus Infections"],"prefix":"10.1007","volume":"375","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4360-1335","authenticated-orcid":false,"given":"Nicholas","family":"Reynolds","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Dearnley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3667-6841","authenticated-orcid":false,"given":"Tracey M.","family":"Hinton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,21]]},"reference":[{"key":"127_CR1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3009872","author":"HD Marston","year":"2014","unstructured":"Marston HD, Folkers GK, Morens DM, Fauci AS (2014) Emerging viral diseases: confronting threats with new technologies. Sci Transl Med. doi:10.1126\/scitranslmed.3009872","journal-title":"Sci Transl Med"},{"key":"127_CR2","unstructured":"The Centers for Disease Control and Prevention (2016) 2014-2016 Ebola Outbreak in West Africa. Available at: https:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/. Accessed 15 Oct 2016"},{"issue":"9","key":"127_CR3","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S1473-3099(12)70121-4","volume":"12","author":"FS Dawood","year":"2009","unstructured":"Dawood FS, Iuliano AD, Reed C, Meltzer MI, Shay DK, Cheng P-Y, Bandaranayake D, Breiman RF, Brooks WA, Buchy P, Feikin DR, Fowler KB, Gordon A, Hien NT, Horby P, Huang QS, Katz MA, Krishnan A, Lal R, Montgomery JM, M\u00f8lbak K, Pebody R, Presanis AM, Razuri H, Steens A, Tinoco YO, Wallinga J, Yu H, Vong S, Bresee J, Widdowson M-A (2009) Estimated global mortality associated with the first 12\u00a0months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis 12(9):687\u2013695. doi:10.1016\/s1473-3099(12)70121-4","journal-title":"Lancet Infect Dis"},{"key":"127_CR4","unstructured":"The World Health Organisation (2016) Emergencies Zika virus and complications. Available at: http:\/\/www.who.int\/emergencies\/zika-virus\/en\/. Accessed 15 Oct 2016"},{"key":"127_CR5","unstructured":"The World Health Organisation (2016) Cumulative number of confirmed human cases of avian influenza A(H5N1) reported to WHO. Available at: http:\/\/www.who.int\/influenza\/human_animal_interface\/H5N1_cumulative_table_archives\/en\/. Accessed 15 Oct 2016"},{"issue":"1798","key":"127_CR6","doi-asserted-by":"publisher","first-page":"20142124","DOI":"10.1098\/rspb.2014.2124","volume":"282","author":"RK Plowright","year":"2015","unstructured":"Plowright RK, Eby P, Hudson PJ, Smith IL, Westcott D, Bryden WL, Middleton D, Reid PA, McFarlane RA, Martin G, Tabor GM, Skerratt LF, Anderson DL, Crameri G, Quammen D, Jordan D, Freeman P, Wang L-F, Epstein JH, Marsh GA, Kung NY, McCallum H (2015) Ecological dynamics of emerging bat virus spillover. Proc R Soc B Biol Sci 282(1798):20142124. doi:10.1098\/rspb.2014.2124","journal-title":"Proc R Soc B Biol Sci"},{"key":"127_CR7","doi-asserted-by":"publisher","DOI":"10.1177\/1040638716658929","author":"PHE Arruda","year":"2016","unstructured":"Arruda PHE, Stevenson GW, Killian ML, Burrough ER, Gauger PC, Harmon KM, Magstadt DR, Yoon K-J, Zhang J, Madson DM, Pi\u00f1eyro P, Derscheid RJ, Schwartz KJ, Cooper VL, Halbur PG, Main RG, Sato Y, Arruda BL (2016) Outbreak of H5N2 highly pathogenic avian Influenza A virus infection in two commercial layer facilities: lesions and viral antigen distribution. J Vet Diagn Invest. doi:10.1177\/1040638716658929","journal-title":"J Vet Diagn Invest"},{"key":"127_CR8","unstructured":"Group WB (2014) The economic impact of the 2014 Ebola epidemic: short and medium term estimates for West Africa. World Bank Group"},{"issue":"3","key":"127_CR9","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1128\/CMR.00102-15","volume":"29","author":"E De Clercq","year":"2016","unstructured":"De Clercq E, Li G (2016) Approved antiviral drugs over the Past 50 Years. Clin Microbiol Rev 29(3):695\u2013747. doi:10.1128\/cmr.00102-15","journal-title":"Clin Microbiol Rev"},{"issue":"98","key":"127_CR10","first-page":"151","volume":"18","author":"D Wang","year":"2014","unstructured":"Wang D, Gao G (2014) State-of-the-art human gene therapy: part II. Gene therapy strategies and applications. Discov Med 18(98):151\u2013161","journal-title":"Discov Med"},{"issue":"4","key":"127_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2165\/00003088-200241040-00002","volume":"41","author":"RS Geary","year":"2002","unstructured":"Geary RS, Henry SP, Grillone LR (2002) Fomivirsen. Clin Pharmacokinet 41(4):255\u2013260. doi:10.2165\/00003088-200241040-00002","journal-title":"Clin Pharmacokinet"},{"issue":"6669","key":"127_CR12","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/35888","volume":"391","author":"A Fire","year":"1998","unstructured":"Fire A, Xu S, Montgomery M, Kostas S, Driver S, Mello C (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391(6669):806\u2013811","journal-title":"Nature"},{"key":"127_CR13","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.2147\/ott.s50483","volume":"7","author":"Chen G-x","year":"2014","unstructured":"G-x Chen, Zhang S, X-h He, S-y Liu, Ma C, Zou X-P (2014) Clinical utility of recombinant adenoviral human p53 gene therapy: current perspectives. OncoTargets Ther 7:1901\u20131909. doi:10.2147\/ott.s50483","journal-title":"OncoTargets Ther"},{"issue":"10","key":"127_CR14","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1038\/mt.2012.194","volume":"20","author":"S Yla-Herttuala","year":"2012","unstructured":"Yla-Herttuala S (2012) Endgame: glybera finally recommended for approval as the first gene therapy drug in the European Union. Mol Ther 20(10):1831\u20131832","journal-title":"Mol Ther"},{"issue":"1","key":"127_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.atherosclerosissup.2010.03.004","volume":"11","author":"D Gaudet","year":"2010","unstructured":"Gaudet D, de Wal J, Tremblay K, D\u00e9ry S, van Deventer S, Freidig A, Brisson D, M\u00e9thot J (2010) Review of the clinical development of alipogene tiparvovec gene therapy for lipoprotein lipase deficiency. Atheroscler Suppl 11(1):55\u201360. doi:10.1016\/j.atherosclerosissup.2010.03.004","journal-title":"Atheroscler Suppl"},{"issue":"7","key":"127_CR16","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/mt.2015.94","volume":"23","author":"Y Fong","year":"2015","unstructured":"Fong Y (2015) Oncolytic treatment for cancer recommended for approval. Mol Ther 23(7):1131. doi:10.1038\/mt.2015.94","journal-title":"Mol Ther"},{"key":"127_CR17","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-016-5286-0","author":"RHI Andtbacka","year":"2016","unstructured":"Andtbacka RHI, Ross M, Puzanov I, Milhem M, Collichio F, Delman KA, Amatruda T, Zager JS, Cranmer L, Hsueh E, Chen L, Shilkrut M, Kaufman HL (2016) Patterns of clinical response with talimogene laherparepvec (T-VEC) in patients with melanoma treated in the OPTiM Phase III Clinical Trial. Ann Surg Oncol. doi:10.1245\/s10434-016-5286-0","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"127_CR18","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/mt.2016.98","volume":"24","author":"S Yla-Herttuala","year":"2016","unstructured":"Yla-Herttuala S (2016) ADA-SCID gene therapy endorsed by european medicines agency for marketing authorization. Mol Ther 24(6):1013\u20131014. doi:10.1038\/mt.2016.98","journal-title":"Mol Ther"},{"key":"127_CR19","doi-asserted-by":"publisher","unstructured":"Rader DJ, Kastelein JJP (2014) Lomitapide and mipomersen. Two first-in-class drugs for reducing low-density lipoprotein cholesterol in patients with homozygous familial. Hypercholesterolemia 129(9):1022\u20131032. doi:10.1161\/circulationaha.113.001292","DOI":"10.1161\/circulationaha.113.001292"},{"issue":"7","key":"127_CR20","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s40265-015-0391-0","volume":"75","author":"I Marafini","year":"2015","unstructured":"Marafini I, Di Fusco D, Calabrese E, Sedda S, Pallone F, Monteleone G (2015) Antisense approach to inflammatory bowel disease: prospects and challenges. Drugs 75(7):723\u2013730. doi:10.1007\/s40265-015-0391-0","journal-title":"Drugs"},{"issue":"12","key":"127_CR21","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nrd4685","volume":"14","author":"JE Zuckerman","year":"2015","unstructured":"Zuckerman JE, Davis ME (2015) Clinical experiences with systemically administered siRNA-based therapeutics in cancer. Nat Rev Drug Discov 14(12):843\u2013856. doi:10.1038\/nrd4685","journal-title":"Nat Rev Drug Discov"},{"issue":"1513","key":"127_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1098\/rstb.2008.0168","volume":"364","author":"DJ Obbard","year":"2009","unstructured":"Obbard DJ, Gordon KHJ, Buck AH, Jiggins FM (2009) The evolution of RNAi as a defence against viruses and transposable elements. Philos Trans R Soc B Biol Sci 364(1513):99\u2013115. doi:10.1098\/rstb.2008.0168","journal-title":"Philos Trans R Soc B Biol Sci"},{"issue":"2","key":"127_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00294-006-0078-x","volume":"50","author":"H Cerutti","year":"2006","unstructured":"Cerutti H, Casas-Mollano JA (2006) On the origin and functions of RNA-mediated silencing: from protists to man. Curr Genet 50(2):81\u201399. doi:10.1007\/s00294-006-0078-x","journal-title":"Curr Genet"},{"issue":"23","key":"127_CR24","doi-asserted-by":"publisher","first-page":"13959","DOI":"10.1073\/pnas.95.23.13959","volume":"95","author":"PM Waterhouse","year":"1998","unstructured":"Waterhouse PM, Graham MW, Wang M-B (1998) Virus resistance and gene silencing in plants can be induced by simultaneous expression of sense and antisense RNA. Proc Natl Acad Sci 95(23):13959\u201313964. doi:10.1073\/pnas.95.23.13959","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"127_CR25","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1242\/dev.113.2.503","volume":"113","author":"A Fire","year":"1991","unstructured":"Fire A, Albertson D, Harrison SW, Moerman DG (1991) Production of antisense RNA leads to effective and specific inhibition of gene expression in C. elegans muscle. Development 113(2):503\u2013514","journal-title":"Development"},{"issue":"4","key":"127_CR26","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/0092-8674(95)90082-9","volume":"81","author":"S Guo","year":"1995","unstructured":"Guo S, Kemphues KJ (1995) Par-1, a gene required for establishing polarity in C. elegans embryos, encodes a putative Ser\/Thr kinase that is asymmetrically distributed. Cell 81(4):611\u2013620. doi:10.1016\/0092-8674(95)90082-9","journal-title":"Cell"},{"issue":"6836","key":"127_CR27","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/35078107","volume":"411","author":"SM Elbashir","year":"2001","unstructured":"Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411(6836):494\u2013498","journal-title":"Nature"},{"issue":"3","key":"127_CR28","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nm828","volume":"9","author":"E Song","year":"2003","unstructured":"Song E, Lee S-K, Wang J, Ince N, Ouyang N, Min J, Chen J, Shankar P, Lieberman J (2003) RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 9(3):347\u2013351","journal-title":"Nat Med"},{"issue":"3","key":"127_CR29","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1021\/mp900015y","volume":"6","author":"ME Davis","year":"2009","unstructured":"Davis ME (2009) The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. Mol Pharm 6(3):659\u2013668. doi:10.1021\/mp900015y","journal-title":"Mol Pharm"},{"key":"127_CR30","unstructured":"Bender E (2014) The second coming of RNAi. The scientist, vol. 28. LabX Media Group"},{"issue":"18","key":"127_CR31","doi-asserted-by":"publisher","first-page":"R789","DOI":"10.1016\/j.cub.2007.07.014","volume":"17","author":"C Matranga","year":"2007","unstructured":"Matranga C, Zamore PD (2007) Small silencing RNAs. Curr Biol 17(18):R789\u2013R793. doi:10.1016\/j.cub.2007.07.014","journal-title":"Curr Biol"},{"issue":"11","key":"127_CR32","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.tcb.2015.07.011","volume":"25","author":"Iwakawa H-o","year":"2015","unstructured":"H-o Iwakawa, Tomari Y (2015) The functions of MicroRNAs: mRNA decay and translational repression. Trends Cell Biol 25(11):651\u2013665. doi:10.1016\/j.tcb.2015.07.011","journal-title":"Trends Cell Biol"},{"issue":"10a","key":"127_CR33","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1101\/gr.2722704","volume":"14","author":"A Rodriguez","year":"2004","unstructured":"Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A (2004) Identification of mammalian microRNA host genes and transcription units. Genome Res 14(10a):1902\u20131910. doi:10.1101\/gr.2722704","journal-title":"Genome Res"},{"key":"127_CR34","doi-asserted-by":"crossref","unstructured":"Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, Lee J, Provost P, Radmark O, Kim S, Kim VN (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature 425(6956):415\u2013419. doi:http:\/\/www.nature.com\/nature\/journal\/v425\/n6956\/suppinfo\/nature01957_S1.html","DOI":"10.1038\/nature01957"},{"issue":"23","key":"127_CR35","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/j.cub.2004.11.001","volume":"14","author":"M Landthaler","year":"2004","unstructured":"Landthaler M, Yalcin A, Tuschl T (2004) The human digeorge syndrome critical region gene 8 and its D. melanogaster homolog are required for miRNA biogenesis. Curr Biol 14(23):2162\u20132167. doi:10.1016\/j.cub.2004.11.001","journal-title":"Curr Biol"},{"issue":"24","key":"127_CR36","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1101\/gad.1158803","volume":"17","author":"R Yi","year":"2003","unstructured":"Yi R, Qin Y, Macara IG, Cullen BR (2003) Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 17(24):3011\u20133016. doi:10.1101\/gad.1158803","journal-title":"Genes Dev"},{"issue":"1","key":"127_CR37","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1146\/annurev-biophys-083012-130404","volume":"42","author":"RC Wilson","year":"2013","unstructured":"Wilson RC, Doudna JA (2013) Molecular mechanisms of RNA interference. Annu Rev Biophys 42(1):217\u2013239. doi:10.1146\/annurev-biophys-083012-130404","journal-title":"Annu Rev Biophys"},{"issue":"5567","key":"127_CR38","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1126\/science.1068999","volume":"296","author":"TR Brummelkamp","year":"2002","unstructured":"Brummelkamp TR, Bernards R, Agami R (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296(5567):550\u2013553. doi:10.1126\/science.1068999","journal-title":"Science"},{"key":"127_CR39","doi-asserted-by":"crossref","unstructured":"Silva JM, Li MZ, Chang K, Ge W, Golding MC, Rickles RJ, Siolas D, Hu G, Paddison PJ, Schlabach MR, Sheth N, Bradshaw J, Burchard J, Kulkarni A, Cavet G, Sachidanandam R, McCombie WR, Cleary MA, Elledge SJ, Hannon GJ (2005) Second-generation shRNA libraries covering the mouse and human genomes. Nat Genet 37 (11):1281\u20131288. doi:http:\/\/www.nature.com\/ng\/journal\/v37\/n11\/suppinfo\/ng1650_S1.html","DOI":"10.1038\/ng1650"},{"issue":"6","key":"127_CR40","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.celrep.2013.11.020","volume":"5","author":"C Fellmann","year":"2013","unstructured":"Fellmann C, Hoffmann T, Sridhar V, Hopfgartner B, Muhar M, Roth M, Lai Dan Y, Barbosa In\u00eas AM, Kwon Jung S, Guan Y, Sinha N, Zuber J (2013) An optimized microRNA backbone for effective single-copy RNAi. Cell Rep 5(6):1704\u20131713. doi:10.1016\/j.celrep.2013.11.020","journal-title":"Cell Rep"},{"key":"127_CR41","doi-asserted-by":"crossref","unstructured":"ter Brake O, Konstantinova P, Ceylan M, Berkhout B (2006) Silencing of HIV-1 with RNA interference: a multiple shRNA approach. Mol Ther 14(6):883\u2013892. doi:http:\/\/www.nature.com\/mt\/journal\/v14\/n6\/suppinfo\/mt20061372s1.html","DOI":"10.1016\/j.ymthe.2006.07.007"},{"issue":"9","key":"127_CR42","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1093\/nar\/gkn109","volume":"36","author":"YP Liu","year":"2008","unstructured":"Liu YP, Haasnoot J, ter Brake O, Berkhout B, Konstantinova P (2008) Inhibition of HIV-1 by multiple siRNAs expressed from a single microRNA polycistron. Nucleic Acids Res 36(9):2811\u20132824. doi:10.1093\/nar\/gkn109","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"127_CR43","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00280-006-0318-2","volume":"58","author":"SM Hammond","year":"2006","unstructured":"Hammond SM (2006) RNAi, microRNAs, and human disease. Cancer Chemother Pharmacol 58(1):63\u201368. doi:10.1007\/s00280-006-0318-2","journal-title":"Cancer Chemother Pharmacol"},{"key":"127_CR44","doi-asserted-by":"crossref","unstructured":"Dickey LL, Hanley TM, Huffaker TB, Ramstead AG, O\u2019Connell RM (2017) Lane TE MicroRNA 155 and viral-induced neuroinflammation. J Neuroimmunol. doi:http:\/\/dx.doi.org\/10.1016\/j.jneuroim.2017.01.016","DOI":"10.1016\/j.jneuroim.2017.01.016"},{"issue":"1","key":"127_CR45","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.molmed.2016.11.003","volume":"23","author":"DW Trobaugh","year":"2017","unstructured":"Trobaugh DW, Klimstra WB (2017) MicroRNA regulation of RNA virus replication and pathogenesis. Trends Mol Med 23(1):80\u201393. doi:10.1016\/j.molmed.2016.11.003","journal-title":"Trends Mol Med"},{"key":"127_CR46","doi-asserted-by":"crossref","unstructured":"Grimm D, Streetz KL, Jopling CL, Storm TA, Pandey K, Davis CR, Marion P, Salazar F, Kay MA (2006) Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways. Nature 441(7092):537\u2013541. doi:http:\/\/www.nature.com\/nature\/journal\/v441\/n7092\/suppinfo\/nature04791_S1.html","DOI":"10.1038\/nature04791"},{"issue":"2","key":"127_CR47","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.antiviral.2008.05.009","volume":"80","author":"TM Hinton","year":"2008","unstructured":"Hinton TM, Doran TJ (2008) Inhibition of chicken anaemia virus replication using multiple short-hairpin RNAs. Antiviral Res 80(2):143\u2013149. doi:10.1016\/j.antiviral.2008.05.009","journal-title":"Antiviral Res"},{"issue":"9","key":"127_CR48","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1128\/AAC.00014-09","volume":"53","author":"R Alvarez","year":"2009","unstructured":"Alvarez R, Elbashir S, Borland T, Toudjarska I, Hadwiger P, John M, Roehl I, Morskaya SS, Martinello R, Kahn J, Van Ranst M, Tripp RA, DeVincenzo JP, Pandey R, Maier M, Nechev L, Manoharan M, Kotelianski V, Meyers R (2009) RNA interference-mediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy. Antimicrob Agents Chemother 53(9):3952\u20133962. doi:10.1128\/aac.00014-09","journal-title":"Antimicrob Agents Chemother"},{"key":"127_CR49","doi-asserted-by":"publisher","unstructured":"Barik S (2009) Treating respiratory viral diseases with chemically modified, second generation intranasal siRNAs. In: Sioud M (ed) siRNA and miRNA gene silencing: from bench to bedside. Humana Press, Totowa, NJ, pp 1\u201311. doi:10.1007\/978-1-60327-547-7_16","DOI":"10.1007\/978-1-60327-547-7_16"},{"issue":"2","key":"127_CR50","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3201\/eid2202.151796","volume":"22","author":"T Hoenen","year":"2016","unstructured":"Hoenen T, Groseth A, Rosenke K, Fischer RJ, Hoenen A, Judson SD, Martellaro C, Falzarano D, Marzi A, Squires RB, Wollenberg KR, de Wit E, Prescott J, Safronetz D, van Doremalen N, Bushmaker T, Feldmann F, McNally K, Bolay FK, Fields B, Sealy T, Rayfield M, Nichol ST, Zoon KC, Massaquoi M, Munster VJ, Feldmann H (2016) Nanopore sequencing as a rapidly deployable ebola outbreak tool. Emerg Infect Dis 22(2):331\u2013334. doi:10.3201\/eid2202.151796","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"127_CR51","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.3201\/eid2107.150522","volume":"21","author":"RK Jeffrey","year":"2015","unstructured":"Jeffrey RK, Michael RW, Suzanne M, Jason TL, Brett B, Lawrence F, Fahn T, Karla P, Joseph WD, Timothy M, Randal JS, Kurt ES, James P, Stacey B, Joseph F, Jens HK, Lisa H, Daniel JP, Pardis CS, Mariano S-L, Fatorma KB, Gustavo P (2015) Monitoring of Ebola virus makona evolution through establishment of advanced genomic capability in liberia. Emerg Infect Dis J 21(7):1135. doi:10.3201\/eid2107.150522","journal-title":"Emerg Infect Dis J"},{"key":"127_CR52","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13073-015-0220-9","volume":"7","author":"AL Greninger","year":"2015","unstructured":"Greninger AL, Naccache SN, Federman S, Yu G, Mbala P, Bres V, Stryke D, Bouquet J, Somasekar S, Linnen JM, Dodd R, Mulembakani P, Schneider BS, Muyembe-Tamfum J-J, Stramer SL, Chiu CY (2015) Rapid metagenomic identification of viral pathogens in clinical samples by real-time nanopore sequencing analysis. Genome Med 7:99. doi:10.1186\/s13073-015-0220-9","journal-title":"Genome Med"},{"issue":"Web Server issu","key":"127_CR53","doi-asserted-by":"publisher","first-page":"W-130","DOI":"10.1093\/nar\/gkh366","volume":"32","author":"B Yuan","year":"2004","unstructured":"Yuan B, Latek R, Hossbach M, Tuschl T, Lewitter F (2004) siRNA selection server: an automated siRNA oligonucleotide prediction server. Nucleic Acids Res 32(Web Server issue):W-130\u2013W-134. doi:10.1093\/nar\/gkh366","journal-title":"Nucleic Acids Res"},{"issue":"Web Server issu","key":"127_CR54","doi-asserted-by":"publisher","first-page":"W-104","DOI":"10.1093\/nar\/gkn250","volume":"36","author":"ZJ Lu","year":"2008","unstructured":"Lu ZJ, Mathews DH (2008) OligoWalk: an online siRNA design tool utilizing hybridization thermodynamics. Nucleic Acids Research 36(Web Server issue):W-104\u2013W-108. doi:10.1093\/nar\/gkn250","journal-title":"Nucleic Acids Research"},{"key":"127_CR55","doi-asserted-by":"publisher","unstructured":"Tedebark U, Scozzari A, Werbitzky O, Capaldi D, Holmberg L (2011) Industrial-scale manufacturing of a possible oligonucleotide cargo CPP-based drug. In: Langel \u00dc (ed) Cell-penetrating peptides: methods and protocols. Humana Press, Totowa, pp 505\u2013524. doi:10.1007\/978-1-60761-919-2_36","DOI":"10.1007\/978-1-60761-919-2_36"},{"issue":"3","key":"127_CR56","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1261\/rna.348307","volume":"13","author":"AP Aalto","year":"2007","unstructured":"Aalto AP, Sarin LP, van Dijk AA, Saarma M, Poranen MM, Arum\u00e4e U, Bamford DH (2007) Large-scale production of dsRNA and siRNA pools for RNA interference utilizing bacteriophage \u03d56 RNA-dependent RNA polymerase. RNA 13(3):422\u2013429. doi:10.1261\/rna.348307","journal-title":"RNA"},{"issue":"7552","key":"127_CR57","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nature14442","volume":"521","author":"EP Thi","year":"2015","unstructured":"Thi EP, Mire CE, Lee ACH, Geisbert JB, Zhou JZ, Agans KN, Snead NM, Deer DJ, Barnard TR, Fenton KA, MacLachlan I, Geisbert TW (2015) Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates. Nature 521(7552):362\u2013365. doi:10.1038\/nature14442","journal-title":"Nature"},{"key":"127_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.24578","author":"H Paavilainen","year":"2016","unstructured":"Paavilainen H, Lehtinen J, Romanovskaya A, Nyg\u00e5rdas M, Bamford DH, Poranen MM, Hukkanen V (2016) Inhibition of clinical pathogenic herpes simplex virus 1 strains with enzymatically created siRNA pools. J Med Virol. doi:10.1002\/jmv.24578","journal-title":"J Med Virol"},{"issue":"1","key":"127_CR59","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jconrel.2012.06.008","volume":"162","author":"JM Steinbach","year":"2012","unstructured":"Steinbach JM, Weller CE, Booth CJ, Saltzman WM (2012) Polymer nanoparticles encapsulating siRNA for treatment of HSV-2 genital infection. J Controlled Release 162(1):102\u2013110. doi:10.1016\/j.jconrel.2012.06.008","journal-title":"J Controlled Release"},{"issue":"9","key":"127_CR60","doi-asserted-by":"publisher","first-page":"5196","DOI":"10.4049\/jimmunol.169.9.5196","volume":"169","author":"J Capodici","year":"2002","unstructured":"Capodici J, Karik\u00f3 K, Weissman D (2002) Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference. J Immunol 169(9):5196\u20135201. doi:10.4049\/jimmunol.169.9.5196","journal-title":"J Immunol"},{"issue":"9","key":"127_CR61","doi-asserted-by":"publisher","first-page":"135288","DOI":"10.1371\/journal.pone.0135288","volume":"10","author":"S Boyapalle","year":"2015","unstructured":"Boyapalle S, Xu W, Raulji P, Mohapatra S, Mohapatra SS (2015) A multiple siRNA-based anti-HIV\/SHIV microbicide shows protection in both In Vitro and In Vivo models. PLoS One 10(9):135288. doi:10.1371\/journal.pone.0135288","journal-title":"PLoS One"},{"issue":"4","key":"127_CR62","doi-asserted-by":"publisher","first-page":"e312","DOI":"10.1038\/mtna.2016.24","volume":"5","author":"F Spanevello","year":"2016","unstructured":"Spanevello F, Calistri A, Del Vecchio C, Mantelli B, Frasson C, Basso G, Pal\u00f9 G, Cavazzana M, Parolin C (2016) Development of lentiviral vectors simultaneously expressing multiple siRNAs against CCR5, vif and tat\/rev genes for an HIV-1 gene therapy approach. Mol Ther Nucleic Acids 5(4):e312. doi:10.1038\/mtna.2016.24","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"127_CR63","doi-asserted-by":"publisher","first-page":"e0146710","DOI":"10.1371\/journal.pone.0146710","volume":"11","author":"J-S Moon","year":"2016","unstructured":"Moon J-S, Lee S-H, Kim E-J, Cho H, Lee W, Kim G-W, Park H-J, Cho S-W, Lee C, Oh J-W (2016) Inhibition of hepatitis C virus in mice by a small interfering RNA targeting a highly conserved sequence in viral IRES Pseudoknot. PLoS One 11(1):e0146710. doi:10.1371\/journal.pone.0146710","journal-title":"PLoS One"},{"issue":"1","key":"127_CR64","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.virusres.2004.01.012","volume":"102","author":"S Barik","year":"2004","unstructured":"Barik S (2004) Control of nonsegmented negative-strand RNA virus replication by siRNA. Virus Res 102(1):27\u201335. doi:10.1016\/j.virusres.2004.01.012","journal-title":"Virus Res"},{"issue":"1\u20133","key":"127_CR65","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0014-5793(03)00400-9","volume":"543","author":"K Hamasaki","year":"2003","unstructured":"Hamasaki K, Nakao K, Matsumoto K, Ichikawa T, Ishikawa H, Eguchi K (2003) Short interfering RNA-directed inhibition of hepatitis B virus replication. FEBS Lett 543(1\u20133):51\u201354. doi:10.1016\/s0014-5793(03)00400-9","journal-title":"FEBS Lett"},{"issue":"1\u20132","key":"127_CR66","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ijpharm.2010.08.026","volume":"400","author":"J Wang","year":"2010","unstructured":"Wang J, Feng S-S, Wang S, Z-y Chen (2010) Evaluation of cationic nanoparticles of biodegradable copolymers as siRNA delivery system for hepatitis B treatment. Int J Pharm 400(1\u20132):194\u2013200. doi:10.1016\/j.ijpharm.2010.08.026","journal-title":"Int J Pharm"},{"issue":"3","key":"127_CR67","doi-asserted-by":"publisher","first-page":"210","DOI":"10.5468\/ogs.2015.58.3.210","volume":"58","author":"JS Cho","year":"2015","unstructured":"Cho JS, Lee S-W, Kim Y-M, Kim D, Kim D-Y, Kim Y-T (2015) Long (27-nucleotides) small inhibitory RNAs targeting E6 protein eradicate effectively the cervical cancer cells harboring human papilloma virus. Obstet Gynecol Sci 58(3):210\u2013216","journal-title":"Obstet Gynecol Sci"},{"issue":"12","key":"127_CR68","doi-asserted-by":"publisher","first-page":"5951","DOI":"10.1128\/JVI.02453-05","volume":"80","author":"T Reuter","year":"2006","unstructured":"Reuter T, Weissbrich B, Schneider-Schaulies S, Schneider-Schaulies J (2006) RNA interference with measles virus N, P, and L mRNAs efficiently prevents and with matrix protein mRNA enhances viral transcription. J Virol 80(12):5951\u20135957. doi:10.1128\/jvi.02453-05","journal-title":"J Virol"},{"issue":"12","key":"127_CR69","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/embo-reports\/kvf234","volume":"3","author":"MA D\u00e9ctor","year":"2002","unstructured":"D\u00e9ctor MA, Romero P, L\u00f3pez S, Arias CF (2002) Rotavirus gene silencing by small interfering RNAs. EMBO Rep 3(12):1175","journal-title":"EMBO Rep"},{"issue":"5","key":"127_CR70","doi-asserted-by":"publisher","first-page":"e64360","DOI":"10.1371\/journal.pone.0064360","volume":"8","author":"JL McCaskill","year":"2013","unstructured":"McCaskill JL, Marsh GA, Monaghan P, Wang L-F, Doran T, McMillan NAJ (2013) Potent inhibition of Hendra virus infection via RNA Interference and poly I: C immune activation. PLoS One 8(5):e64360. doi:10.1371\/journal.pone.0064360","journal-title":"PLoS One"},{"issue":"8","key":"127_CR71","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.2217\/nnm.13.119","volume":"9","author":"TM Hinton","year":"2014","unstructured":"Hinton TM, Challagulla A, Stewart CR, Guerrero-Sanchez C, Grusche FA, Shi SN, Bean AG, Monaghan P, Gunatillake PA, Thang SH, Tizard ML (2014) Inhibition of influenza virus in vivo by siRNA delivered using ABA triblock copolymer synthesized by reversible addition-fragmentation chain-transfer polymerization. Nanomedicine 9(8):1141\u20131154. doi:10.2217\/nnm.13.119","journal-title":"Nanomedicine"},{"issue":"23","key":"127_CR72","doi-asserted-by":"publisher","first-page":"8682","DOI":"10.1073\/pnas.0402630101","volume":"101","author":"SM Tompkins","year":"2004","unstructured":"Tompkins SM, Lo C-Y, Tumpey TM, Epstein SL (2004) Protection against lethal influenza virus challenge by RNA interference in vivo. Proc Natl Acad Sci USA 101(23):8682\u20138686. doi:10.1073\/pnas.0402630101","journal-title":"Proc Natl Acad Sci USA"},{"issue":"23","key":"127_CR73","doi-asserted-by":"publisher","first-page":"8676","DOI":"10.1073\/pnas.0402486101","volume":"101","author":"Q Ge","year":"2004","unstructured":"Ge Q, Filip L, Bai A, Nguyen T, Eisen HN, Chen J (2004) Inhibition of influenza virus production in virus-infected mice by RNA interference. Proc Natl Acad Sci USA 101(23):8676\u20138681. doi:10.1073\/pnas.0402486101","journal-title":"Proc Natl Acad Sci USA"},{"key":"127_CR74","doi-asserted-by":"crossref","unstructured":"Li B-j, Tang Q, Cheng D, Qin C, Xie FY, Wei Q, Xu J, Liu Y, Zheng B-j, Woodle MC, Zhong N, Lu PY (2005) Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque. Nat Med 11(9):944\u2013951. doi:http:\/\/www.nature.com\/nm\/journal\/v11\/n9\/suppinfo\/nm1280_S1.html","DOI":"10.1038\/nm1280"},{"key":"127_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jviromet.2013.12.016","volume":"199","author":"MI Gismondi","year":"2014","unstructured":"Gismondi MI, Ortiz XP, Curr\u00e1 AP, Asurmendi S, Taboga O (2014) Artificial microRNAs as antiviral strategy to FMDV: structural implications of target selection. J Virol Methods 199:1\u201310. doi:10.1016\/j.jviromet.2013.12.016","journal-title":"J Virol Methods"},{"issue":"2\u20134","key":"127_CR76","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.vetmic.2006.09.008","volume":"119","author":"LS Lambeth","year":"2007","unstructured":"Lambeth LS, Moore RJ, Muralitharan MS, Doran TJ (2007) Suppression of bovine viral diarrhea virus replication by small interfering RNA and short hairpin RNA-mediated RNA interference. Vet Microbiol 119(2\u20134):132\u2013143. doi:10.1016\/j.vetmic.2006.09.008","journal-title":"Vet Microbiol"},{"issue":"2","key":"127_CR77","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.antiviral.2008.05.009","volume":"80","author":"TM Hinton","year":"2008","unstructured":"Hinton TM, Doran TJ (2008) Inhibition of chicken anaemia virus replication using multiple short-hairpin RNAs. Antiviral Res 80(2):143\u2013149. doi:10.1016\/j.antiviral.2008.05.009 \n                           (S0166-3542(08)00316-1 [pii])","journal-title":"Antiviral Res"},{"issue":"7","key":"127_CR78","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.3382\/ps.2009-00070","volume":"88","author":"M Chen","year":"2009","unstructured":"Chen M, Payne WS, Dunn JR, Chang S, Zhang HM, Hunt HD, Dodgson JB (2009) Retroviral delivery of RNA interference against Marek\u2019s disease virus in vivo. Poult Sci 88(7):1373\u20131380. doi:10.3382\/ps.2009-00070","journal-title":"Poult Sci"},{"issue":"26","key":"127_CR79","doi-asserted-by":"publisher","first-page":"7967","DOI":"10.1021\/bi0343774","volume":"42","author":"DA Braasch","year":"2003","unstructured":"Braasch DA, Jensen S, Liu Y, Kaur K, Arar K, White MA, Corey DR (2003) RNA interference in mammalian cells by chemically-modified RNA. Biochemistry 42(26):7967\u20137975. doi:10.1021\/bi0343774","journal-title":"Biochemistry"},{"issue":"8","key":"127_CR80","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1124\/dmd.106.009555","volume":"34","author":"van de Water FM, Boerman OC, Wouterse AC, Peters JGP, Russel FGM, Masereeuw R","year":"2006","unstructured":"van de Water FM, Boerman OC, Wouterse AC, Peters JGP, Russel FGM, Masereeuw R (2006) Intravenously administered short interfering RNA accumulates in the kidney and selectively suppresses gene function in renal proximal tubules. Drug Metab Dispos 34(8):1393\u20131397. doi:10.1124\/dmd.106.009555","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"127_CR81","doi-asserted-by":"publisher","first-page":"978","DOI":"10.2967\/jnumed.109.069906","volume":"51","author":"L Kang","year":"2010","unstructured":"Kang L, Wang RF, Yan P, Liu M, Zhang CL, Yu MM, Cui YG, Xu XJ (2010) Noninvasive visualization of RNA delivery with 99mTc-radiolabeled small-interference RNA in tumor xenografts. J Nucl Med 51(6):978\u2013986. doi:10.2967\/jnumed.109.069906","journal-title":"J Nucl Med"},{"key":"127_CR82","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2016.1227781","author":"SA Shorter","year":"2016","unstructured":"Shorter SA, Gollings AS, Gorringe-Pattrick MAM, Coakley JE, Dyer PDR, Richardson SCW (2016) The potential of toxin-based drug delivery systems for enhanced nucleic acid therapeutic delivery. Expert Opin Drug Deliv. doi:10.1080\/17425247.2016.1227781","journal-title":"Expert Opin Drug Deliv"},{"key":"127_CR83","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-016-0352-5","author":"DK Mishra","year":"2017","unstructured":"Mishra DK, Balekar N, Mishra PK (2017) Nanoengineered strategies for siRNA delivery: from target assessment to cancer therapeutic efficacy. Drug Deliv Transl Res. doi:10.1007\/s13346-016-0352-5","journal-title":"Drug Deliv Transl Res"},{"key":"127_CR84","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jconrel.2016.11.017","volume":"245","author":"A Mokhtarzadeh","year":"2017","unstructured":"Mokhtarzadeh A, Alibakhshi A, Hashemi M, Hejazi M, Hosseini V, de la Guardia M, Ramezani M (2017) Biodegradable nano-polymers as delivery vehicles for therapeutic small non-coding ribonucleic acids. J Controll Release 245:116\u2013126. doi:10.1016\/j.jconrel.2016.11.017","journal-title":"J Controll Release"},{"key":"127_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2016.08.012","author":"HR Lakkireddy","year":"2016","unstructured":"Lakkireddy HR, Bazile D (2016) Building the design, translation and development principles of polymeric nanomedicines using the case of clinically advanced poly(lactide(glycolide))-poly(ethylene glycol) nanotechnology as a model: an industrial viewpoint. Adv Drug Deliv Rev. doi:10.1016\/j.addr.2016.08.012","journal-title":"Adv Drug Deliv Rev"},{"issue":"27","key":"127_CR86","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1002\/smll.201503866","volume":"12","author":"C Chen","year":"2016","unstructured":"Chen C, Posocco P, Liu X, Cheng Q, Laurini E, Zhou J, Liu C, Wang Y, Tang J, Col VD, Yu T, Giorgio S, Fermeglia M, Qu F, Liang Z, Rossi JJ, Liu M, Rocchi P, Pricl S, Peng L (2016) Mastering dendrimer self-assembly for efficient siRNA delivery: from conceptual design to In vivo efficient gene silencing. Small 12(27):3667\u20133676. doi:10.1002\/smll.201503866","journal-title":"Small"},{"key":"127_CR87","doi-asserted-by":"crossref","unstructured":"Leung AKK, Tam YYC, Cullis PR (2014) Chapter four\u2014lipid nanoparticles for short interfering RNA delivery. In: Leaf Huang DL, Ernst W (eds) Advances in genetics, vol. 88, Academic Press, pp 71\u2013110. doi:http:\/\/dx.doi.org\/10.1016\/B978-0-12-800148-6.00004-3","DOI":"10.1016\/B978-0-12-800148-6.00004-3"},{"issue":"1","key":"127_CR88","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jconrel.2006.04.014","volume":"114","author":"H Lv","year":"2006","unstructured":"Lv H, Zhang S, Wang B, Cui S, Yan J (2006) Toxicity of cationic lipids and cationic polymers in gene delivery. J Controlled Release 114(1):100\u2013109. doi:10.1016\/j.jconrel.2006.04.014","journal-title":"J Controlled Release"},{"key":"127_CR89","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.2147\/IJN.S106625","volume":"11","author":"TS Zatsepin","year":"2016","unstructured":"Zatsepin TS, Kotelevtsev YV, Koteliansky V (2016) Lipid nanoparticles for targeted siRNA delivery\u2014going from bench to bedside. Int J Nanomed 11:3077\u20133086. doi:10.2147\/ijn.s106625","journal-title":"Int J Nanomed"},{"issue":"3","key":"127_CR90","first-page":"311","volume":"3","author":"X-H Peng","year":"2008","unstructured":"Peng X-H, Qian X, Mao H, Wang AY, Chen Z, Nie S, Shin DM (2008) Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy. Int J Nanomed 3(3):311\u2013321","journal-title":"Int J Nanomed"},{"issue":"5","key":"127_CR91","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1021\/bc060367e","volume":"18","author":"AM Derfus","year":"2007","unstructured":"Derfus AM, Chen AA, Min D-H, Ruoslahti E, Bhatia SN (2007) Targeted quantum dot conjugates for siRNA delivery. Bioconj Chem 18(5):1391\u20131396. doi:10.1021\/bc060367e","journal-title":"Bioconj Chem"},{"issue":"11","key":"127_CR92","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.3390\/v5112898","volume":"5","author":"DL DiGiusto","year":"2013","unstructured":"DiGiusto DL, Stan R, Krishnan A, Li H, Rossi JJ, Zaia JA (2013) Development of hematopoietic stem cell based gene therapy for HIV-1 infection: considerations for proof of concept studies and translation to standard medical practice. Viruses 5(11):2898\u20132919. doi:10.3390\/v5112898","journal-title":"Viruses"},{"issue":"4","key":"127_CR93","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1021\/jm049167j","volume":"48","author":"CR Allerson","year":"2005","unstructured":"Allerson CR, Sioufi N, Jarres R, Prakash TP, Naik N, Berdeja A, Wanders L, Griffey RH, Swayze EE, Bhat B (2005) Fully 2\u2032-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA. J Med Chem 48(4):901\u2013904. doi:10.1021\/jm049167j","journal-title":"J Med Chem"},{"issue":"9","key":"127_CR94","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1261\/rna.5103703","volume":"9","author":"Y-L Chiu","year":"2003","unstructured":"Chiu Y-L, Rana TM (2003) siRNA function in RNAi: a chemical modification analysis. RNA-a Publ RNA Soc 9(9):1034\u20131048. doi:10.1261\/rna.5103703","journal-title":"RNA-a Publ RNA Soc"},{"issue":"2","key":"127_CR95","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/nar\/gkg147","volume":"31","author":"M Amarzguioui","year":"2003","unstructured":"Amarzguioui M, Holen T, Babaie E, Prydz H (2003) Tolerance for mutations and chemical modifications in a siRNA. Nucleic Acids Res 31(2):589\u2013595. doi:10.1093\/nar\/gkg147","journal-title":"Nucleic Acids Res"},{"issue":"25","key":"127_CR96","doi-asserted-by":"publisher","first-page":"9045","DOI":"10.1021\/bi050574m","volume":"44","author":"M Egli","year":"2005","unstructured":"Egli M, Minasov G, Tereshko V, Pallan PS, Teplova M, Inamati GB, Lesnik EA, Owens SR, Ross BS, Prakash TP, Manoharan M (2005) Probing the influence of stereoelectronic effects on the biophysical properties of oligonucleotides: comprehensive analysis of the RNA affinity, nuclease resistance, and crystal structure of ten 2\u2032-O-ribonucleic acid modifications. Biochemistry 44(25):9045\u20139057. doi:10.1021\/bi050574m","journal-title":"Biochemistry"},{"issue":"3","key":"127_CR97","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.antiviral.2007.11.009","volume":"77","author":"J DeVincenzo","year":"2008","unstructured":"DeVincenzo J, Cehelsky JE, Alvarez R, Elbashir S, Harborth J, Toudjarska I, Nechev L, Murugaiah V, Vliet AV, Vaishnaw AK, Meyers R (2008) Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV). Antiviral Res 77(3):225\u2013231. doi:10.1016\/j.antiviral.2007.11.009","journal-title":"Antiviral Res"},{"issue":"2","key":"127_CR98","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.healun.2015.08.012","volume":"35","author":"J Gottlieb","year":"2016","unstructured":"Gottlieb J, Zamora MR, Hodges T, Musk AW, Sommerwerk U, Dilling D, Arcasoy S, DeVincenzo J, Karsten V, Shah S, Bettencourt BR, Cehelsky J, Nochur S, Gollob J, Vaishnaw A, Simon AR, Glanville AR (2016) ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus infection in lung transplant recipients. J Heart Lung Transpl 35(2):213\u2013221. doi:10.1016\/j.healun.2015.08.012","journal-title":"J Heart Lung Transpl"},{"issue":"19","key":"127_CR99","doi-asserted-by":"publisher","first-page":"8800","DOI":"10.1073\/pnas.0912186107","volume":"107","author":"J DeVincenzo","year":"2010","unstructured":"DeVincenzo J, Lambkin-Williams R, Wilkinson T, Cehelsky J, Nochur S, Walsh E, Meyers R, Gollob J, Vaishnaw A (2010) A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus. Proc Natl Acad Sci USA 107(19):8800\u20138805. doi:10.1073\/pnas.0912186107","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"127_CR100","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1164\/rccm.201003-0422OC","volume":"183","author":"MR Zamora","year":"2011","unstructured":"Zamora MR, Budev M, Rolfe M, Gottlieb J, Humar A, DeVincenzo J, Vaishnaw A, Cehelsky J, Albert G, Nochur S, Gollob JA, Glanville AR (2011) RNA interference therapy in lung transplant patients infected with respiratory syncytial virus. Am J Respir Crit Care Med 183(4):531\u2013538. doi:10.1164\/rccm.201003-0422OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"127_CR101","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2217\/nnm.13.192","volume":"9","author":"Q Lin","year":"2013","unstructured":"Lin Q, Chen J, Zhang Z, Zheng G (2013) Lipid-based nanoparticles in the systemic delivery of siRNA. Nanomedicine 9(1):105\u2013120. doi:10.2217\/nnm.13.192","journal-title":"Nanomedicine"},{"issue":"4","key":"127_CR102","doi-asserted-by":"publisher","first-page":"e1001997","DOI":"10.1371\/journal.pmed.1001997","volume":"13","author":"J Dunning","year":"2016","unstructured":"Dunning J, Sahr F, Rojek A, Gannon F, Carson G, Idriss B, Massaquoi T, Gandi R, Joseph S, Osman HK, Brooks TJG, Simpson AJH, Goodfellow I, Thorne L, Arias A, Merson L, Castle L, Howell-Jones R, Pardinaz-Solis R, Hope-Gill B, Ferri M, Grove J, Kowalski M, Stepniewska K, Lang T, Whitehead J, Olliaro P, Samai M, Horby PW, for the R-TKMtt (2016) Experimental treatment of ebola virus disease with TKM-130803: a single-arm phase 2 clinical trial. PLoS Med 13(4):e1001997. doi:10.1371\/journal.pmed.1001997","journal-title":"PLoS Med"},{"key":"127_CR103","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/393698","author":"RT Mitsuyasu","year":"2011","unstructured":"Mitsuyasu RT, Zack JA, Macpherson JL, Symonds GP (2011) Phase I\/II clinical trials using gene-modified adult hematopoietic stem cells for HIV: lessons learnt. Stem Cells Int. doi:10.4061\/2011\/393698","journal-title":"Stem Cells Int"},{"issue":"7","key":"127_CR104","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1039\/c1py00038a","volume":"2","author":"D Smith","year":"2011","unstructured":"Smith D, Holley AC, McCormick CL (2011) RAFT-synthesized copolymers and conjugates designed for therapeutic delivery of iRNA. Polym Chem 2(7):1428\u20131441. doi:10.1039\/c1py00038a","journal-title":"Polym Chem"},{"issue":"20","key":"127_CR105","doi-asserted-by":"publisher","first-page":"6871","DOI":"10.1021\/ma061453c","volume":"39","author":"CW Scales","year":"2006","unstructured":"Scales CW, Huang FQ, Li N, Vasilieva YA, Ray J, Convertine AJ, McCormick CL (2006) Corona-stabilized interpolyelectrolyte complexes of SiRNA with nonimmunogenic, hydrophilic\/cationic block copolymers prepared by aqueous RAFT polymerization. Macromolecules 39(20):6871\u20136881. doi:10.1021\/ma061453c","journal-title":"Macromolecules"},{"key":"127_CR106","doi-asserted-by":"publisher","first-page":"7631","DOI":"10.1016\/j.biomaterials.2012.06.090","volume":"33","author":"TM Hinton","year":"2012","unstructured":"Hinton TM, Guerrero-Sanchez C, Graham J, Le TPT, Muir BW, Shi S, Tizard ML, Gunatillake P, McLean K, Thang SH (2012) The effect of RAFT-derived cationic block copolymer structure on gene silencing efficiency. Biomaterials 33:7631","journal-title":"Biomaterials"},{"issue":"14","key":"127_CR107","doi-asserted-by":"publisher","first-page":"4941","DOI":"10.1021\/ma900517w","volume":"42","author":"JD Flores","year":"2009","unstructured":"Flores JD, Xu XW, Treat NJ, McCormick CL (2009) Reversible \u201cself-locked\u201d micelles from a zwitterion-containing triblock copolymer. Macromolecules 42(14):4941\u20134945. doi:10.1021\/ma900517w","journal-title":"Macromolecules"},{"issue":"6","key":"127_CR108","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/S1367-5931(02)00400-3","volume":"6","author":"MJ Cloninger","year":"2002","unstructured":"Cloninger MJ (2002) Biological applications of dendrimers. Curr Opin Chem Biol 6(6):742\u2013748. doi:10.1016\/s1367-5931(02)00400-3","journal-title":"Curr Opin Chem Biol"},{"issue":"23","key":"127_CR109","doi-asserted-by":"publisher","first-page":"9181","DOI":"10.1021\/ma402122z","volume":"46","author":"J Rosselgong","year":"2013","unstructured":"Rosselgong J, Williams EGL, Le TP, Grusche F, Hinton TM, Tizard M, Gunatillake P, Thang SH (2013) Core degradable star RAFT polymers: synthesis, polymerization, and degradation studies. Macromolecules 46(23):9181\u20139188. doi:10.1021\/ma402122z","journal-title":"Macromolecules"},{"issue":"7","key":"127_CR110","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1021\/acs.biomac.6b00185","volume":"17","author":"J Teo","year":"2016","unstructured":"Teo J, McCarroll JA, Boyer C, Youkhana J, Sagnella SM, Duong HTT, Liu J, Sharbeen G, Goldstein D, Davis TP, Kavallaris M, Phillips PA (2016) A rationally optimized nanoparticle system for the delivery of RNA interference therapeutics into pancreatic tumors in vivo. Biomacromolecules 17(7):2337\u20132351. doi:10.1021\/acs.biomac.6b00185","journal-title":"Biomacromolecules"},{"issue":"11","key":"127_CR111","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.1021\/acs.biomac.6b01029","volume":"17","author":"M Dearnley","year":"2016","unstructured":"Dearnley M, Reynolds NP, Cass P, Wei X, Shi S, Mohammed AA, Le TP, Gunatillake P, Tizard M, Thang SH, Hinton TM (2016) Comparing gene silencing and physiochemical properties in siRNA bound cationic star-polymer complexes. Biomacromolecules 17(11):3532\u20133546","journal-title":"Biomacromolecules"},{"issue":"6","key":"127_CR112","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.biotechadv.2015.04.008","volume":"33","author":"A Scomparin","year":"2015","unstructured":"Scomparin A, Polyak D, Krivitsky A, Satchi-Fainaro R (2015) Achieving successful delivery of oligonucleotides\u2014from physico-chemical characterization to in vivo evaluation. Biotechnol Adv 33(6):1294\u20131309. doi:10.1016\/j.biotechadv.2015.04.008","journal-title":"Biotechnol Adv"},{"issue":"9","key":"127_CR113","doi-asserted-by":"publisher","first-page":"098101","DOI":"10.1103\/PhysRevLett.107.098101","volume":"107","author":"X Yi","year":"2011","unstructured":"Yi X, Shi X, Gao H (2011) Cellular uptake of elastic nanoparticles. Phys Rev Lett 107(9):098101. doi:10.1103\/PhysRevLett.107.098101","journal-title":"Phys Rev Lett"},{"issue":"31","key":"127_CR114","doi-asserted-by":"publisher","first-page":"11449","DOI":"10.1073\/pnas.1411393111","volume":"111","author":"JE Zuckerman","year":"2014","unstructured":"Zuckerman JE, Gritli I, Tolcher A, Heidel JD, Lim D, Morgan R, Chmielowski B, Ribas A, Davis ME, Yen Y (2014) Correlating animal and human phase Ia\/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA. Proc Natl Acad Sci 111(31):11449\u201311454. doi:10.1073\/pnas.1411393111","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"127_CR115","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1177\/0192623316645860","volume":"44","author":"Y Ramot","year":"2016","unstructured":"Ramot Y, Rotkopf S, Gabai RM, Zorde Khvalevsky E, Muravnik S, Marzoli GA, Domb AJ, Shemi A, Nyska A (2016) Preclinical safety evaluation in rats of a polymeric matrix containing an siRNA drug used as a local and prolonged delivery system for pancreatic cancer therapy. Toxicol Pathol 44(6):856\u2013865. doi:10.1177\/0192623316645860","journal-title":"Toxicol Pathol"},{"issue":"27","key":"127_CR116","doi-asserted-by":"publisher","first-page":"24560","DOI":"10.18632\/oncotarget.4183","volume":"6","author":"T Golan","year":"2015","unstructured":"Golan T, Khvalevsky EZ, Hubert A, Gabai RM, Hen N, Segal A, Domb A, Harari G, David EB, Raskin S, Goldes Y, Goldin E, Eliakim R, Lahav M, Kopleman Y, Dancour A, Shemi A, Galun E (2015) RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients. Oncotarget 6(27):24560\u201324570","journal-title":"Oncotarget"},{"issue":"9","key":"127_CR117","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1039\/C6BM00441E","volume":"4","author":"E Keles","year":"2016","unstructured":"Keles E, Song Y, Du D, Dong W-J, Lin Y (2016) Recent progress in nanomaterials for gene delivery applications. Biomater Sci 4(9):1291\u20131309. doi:10.1039\/c6bm00441e","journal-title":"Biomater Sci"},{"key":"127_CR118","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.antiviral.2015.06.019","volume":"121","author":"RG Gish","year":"2015","unstructured":"Gish RG, Yuen M-F, Chan HLY, Given BD, Lai C-L, Locarnini SA, Lau JYN, Wooddell CI, Schluep T, Lewis DL (2015) Synthetic RNAi triggers and their use in chronic hepatitis B therapies with curative intent. Antiviral Res 121:97\u2013108. doi:10.1016\/j.antiviral.2015.06.019","journal-title":"Antiviral Res"},{"issue":"32","key":"127_CR119","doi-asserted-by":"publisher","first-page":"12982","DOI":"10.1073\/pnas.0703778104","volume":"104","author":"DB Rozema","year":"2007","unstructured":"Rozema DB, Lewis DL, Wakefield DH, Wong SC, Klein JJ, Roesch PL, Bertin SL, Reppen TW, Chu Q, Blokhin AV, Hagstrom JE, Wolff JA (2007) Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes. Proc Natl Acad Sci USA 104(32):12982\u201312987. doi:10.1073\/pnas.0703778104","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"127_CR120","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1021\/acs.molpharmaceut.5b00073","volume":"12","author":"J Gu","year":"2015","unstructured":"Gu J, Yang S, Ho EA (2015) Biodegradable film for the targeted delivery of siRNA-loaded nanoparticles to vaginal immune cells. Mol Pharm 12(8):2889\u20132903. doi:10.1021\/acs.molpharmaceut.5b00073","journal-title":"Mol Pharm"},{"key":"127_CR121","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4081\/idr.2011.2370","volume":"3","author":"SK Eszterhas","year":"2011","unstructured":"Eszterhas SK, Ilonzo NO, Crozier JE, Celaj S, Howell AL (2011) Nanoparticles containing siRNA to silence CD4 and CCR5 reduce expression of these receptors and inhibit HIV-1 infection in human female reproductive tract tissue explants. Infect Dis Rep 3:11","journal-title":"Infect Dis Rep"},{"issue":"5","key":"127_CR122","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.carres.2009.12.017","volume":"345","author":"M Artan","year":"2010","unstructured":"Artan M, Karadeniz F, Karagozlu MZ, Kim M-M, Kim S-K (2010) Anti-HIV-1 activity of low molecular weight sulfated chitooligosaccharides. Carbohydr Res 345(5):656\u2013662. doi:10.1016\/j.carres.2009.12.017","journal-title":"Carbohydr Res"},{"issue":"1","key":"127_CR123","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.carbpol.2012.08.116","volume":"92","author":"S Park","year":"2013","unstructured":"Park S, Jeong EJ, Lee J, Rhim T, Lee SK, Lee KY (2013) Preparation and characterization of nonaarginine-modified chitosan nanoparticles for siRNA delivery. Carbohydr Polym 92(1):57\u201362. doi:10.1016\/j.carbpol.2012.08.116","journal-title":"Carbohydr Polym"},{"issue":"12","key":"127_CR124","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1007\/s11095-010-0255-y","volume":"27","author":"EJB Nielsen","year":"2010","unstructured":"Nielsen EJB, Nielsen JM, Becker D, Karlas A, Prakash H, Glud SZ, Merrison J, Besenbacher F, Meyer TF, Kjems J, Howard KA (2010) Pulmonary gene silencing in transgenic EGFP mice using aerosolised chitosan\/siRNA nanoparticles. Pharm Res 27(12):2520\u20132527. doi:10.1007\/s11095-010-0255-y","journal-title":"Pharm Res"},{"issue":"2","key":"127_CR125","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2217\/nnm.13.204","volume":"9","author":"HY Xue","year":"2014","unstructured":"Xue HY, Liu S, Wong HL (2014) Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine. Nanomedicine (London, England) 9(2):295\u2013312. doi:10.2217\/nnm.13.204","journal-title":"Nanomedicine (London, England)"},{"key":"127_CR126","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1002\/smll.201201962","volume":"9","author":"B Sun","year":"2013","unstructured":"Sun B, Wang X, Ji Z, Li R, Xia T (2013) NLRP3 inflammasome activation induced by engineered nanomaterials. Small (Weinheim an der Bergstrasse, Germany) 9:1595\u20131607. doi:10.1002\/smll.201201962","journal-title":"Small (Weinheim an der Bergstrasse, Germany)"},{"key":"127_CR127","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2013.00013","author":"AE Gregory","year":"2013","unstructured":"Gregory AE, Williamson D, Titball R (2013) Vaccine delivery using nanoparticles. Front Cell Infect Microbiol. doi:10.3389\/fcimb.2013.00013","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"127_CR128","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nri2510","volume":"9","author":"P Marrack","year":"2009","unstructured":"Marrack P, McKee AS, Munks MW (2009) Towards an understanding of the adjuvant action of aluminium. Nat Rev Immunol 9(4):287\u2013293","journal-title":"Nat Rev Immunol"},{"key":"127_CR129","doi-asserted-by":"crossref","unstructured":"Petrilli V, Papin S, Dostert C, Mayor A, Martinon F, Tschopp J (2007) Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ 14(9):1583\u20131589. doi:http:\/\/www.nature.com\/cdd\/journal\/v14\/n9\/suppinfo\/4402195s1.html","DOI":"10.1038\/sj.cdd.4402195"},{"key":"127_CR130","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1743-8977-9-20","volume":"9","author":"ST Stern","year":"2012","unstructured":"Stern ST, Adiseshaiah PP, Crist RM (2012) Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity. Part Fibre Toxicol 9:20. doi:10.1186\/1743-8977-9-20","journal-title":"Part Fibre Toxicol"},{"issue":"12","key":"127_CR131","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1021\/bm900683r","volume":"10","author":"TP Thomas","year":"2009","unstructured":"Thomas TP, Majoros I, Kotlyar A, Mullen D, Banaszak Holl MM, Baker JR (2009) Cationic Poly(amidoamine) dendrimer induces lysosomal apoptotic pathway at therapeutically relevant concentrations. Biomacromolecules 10(12):3207\u20133214. doi:10.1021\/bm900683r","journal-title":"Biomacromolecules"},{"key":"127_CR132","doi-asserted-by":"crossref","unstructured":"Eisenbarth SC, Colegio OR, O\/\u2019Connor W, Sutterwala FS, Flavell RA (2008) Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453(7198):1122\u20131126. doi:http:\/\/www.nature.com\/nature\/journal\/v453\/n7198\/suppinfo\/nature06939_S1.html","DOI":"10.1038\/nature06939"},{"issue":"23","key":"127_CR133","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1016\/j.vaccine.2007.03.045","volume":"25","author":"A Sokolovska","year":"2007","unstructured":"Sokolovska A, Hem SL, HogenEsch H (2007) Activation of dendritic cells and induction of CD4+ T cell differentiation by aluminum-containing adjuvants. Vaccine 25(23):4575\u20134585. doi:10.1016\/j.vaccine.2007.03.045","journal-title":"Vaccine"},{"issue":"2","key":"127_CR134","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1248\/yakushi.127.307","volume":"127","author":"T Akagi","year":"2007","unstructured":"Akagi T, Baba M, Akashi M (2007) Development of vaccine adjuvants using polymeric nanoparticles and their potential applications for anti-HIV vaccine. Yakugaku Zasshi 127(2):307\u2013317. doi:10.1248\/yakushi.127.307","journal-title":"Yakugaku Zasshi"},{"issue":"1","key":"127_CR135","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1146\/annurev-chembioeng-061010-114133","volume":"2","author":"KA Whitehead","year":"2011","unstructured":"Whitehead KA, Dahlman JE, Langer RS, Anderson DG (2011) Silencing or stimulation? siRNA delivery and the immune system. Annu Rev Chem Biomol Eng 2(1):77\u201396. doi:10.1146\/annurev-chembioeng-061010-114133","journal-title":"Annu Rev Chem Biomol Eng"},{"issue":"29","key":"127_CR136","doi-asserted-by":"publisher","first-page":"E4133","DOI":"10.1073\/pnas.1600299113","volume":"113","author":"JS Chahal","year":"2016","unstructured":"Chahal JS, Khan OF, Cooper CL, McPartlan JS, Tsosie JK, Tilley LD, Sidik SM, Lourido S, Langer R, Bavari S, Ploegh HL, Anderson DG (2016) Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose. Proc Natl Acad Sci 113(29):E4133\u2013E4142. doi:10.1073\/pnas.1600299113","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"127_CR137","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1021\/acs.bioconjchem.6b00370","volume":"27","author":"JR Francica","year":"2016","unstructured":"Francica JR, Lynn GM, Laga R, Joyce MG, Ruckwardt TJ, Morabito KM, Chen M, Chaudhuri R, Zhang B, Sastry M, Druz A, Ko K, Choe M, Pechar M, Georgiev IS, Kueltzo LA, Seymour LW, Mascola JR, Kwong PD, Graham BS, Seder RA (2016) Thermoresponsive polymer nanoparticles co-deliver RSV F trimers with a TLR-7\/8 adjuvant. Bioconj Chem 27(10):2372\u20132385. doi:10.1021\/acs.bioconjchem.6b00370","journal-title":"Bioconj Chem"},{"issue":"8","key":"127_CR138","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1021\/acs.bioconjchem.6b00283","volume":"27","author":"K Miyata","year":"2016","unstructured":"Miyata K, Mohri K, Egawa T, Endo R, Morimoto N, Ochiai K, K-i Hiwatari, Tsubaki K, Tobita E, Uto T, Baba M, Sakuma S (2016) Demonstration of d-octaarginine-linked polymers as promising adjuvants for mucosal vaccination through influenza virus challenge. Bioconj Chem 27(8):1865\u20131871. doi:10.1021\/acs.bioconjchem.6b00283","journal-title":"Bioconj Chem"},{"issue":"4","key":"127_CR139","doi-asserted-by":"publisher","first-page":"e0151922","DOI":"10.1371\/journal.pone.0151922","volume":"11","author":"J Hiremath","year":"2016","unstructured":"Hiremath J, K-i Kang, Xia M, Elaish M, Binjawadagi B, Ouyang K, Dhakal S, Arcos J, Torrelles JB, Jiang X, Lee CW, Renukaradhya GJ (2016) Entrapment of H1N1 influenza virus derived conserved peptides in PLGA nanoparticles enhances T cell response and vaccine efficacy in pigs. PLoS One 11(4):e0151922. doi:10.1371\/journal.pone.0151922","journal-title":"PLoS One"},{"issue":"42","key":"127_CR140","doi-asserted-by":"publisher","first-page":"5114","DOI":"10.1016\/j.vaccine.2016.08.053","volume":"34","author":"I Sarkar","year":"2016","unstructured":"Sarkar I, Garg R, van Drunen Littel-van den Hurk S (2016) Formulation of the respiratory syncytial virus fusion protein with a polymer-based combination adjuvant promotes transient and local innate immune responses and leads to improved adaptive immunity. Vaccine 34(42):5114\u20135124. doi:10.1016\/j.vaccine.2016.08.053","journal-title":"Vaccine"},{"issue":"11","key":"127_CR141","doi-asserted-by":"publisher","first-page":"5764","DOI":"10.1128\/JVI.02202-09","volume":"84","author":"M Bivas-Benita","year":"2010","unstructured":"Bivas-Benita M, Bar L, Gillard GO, Kaufman DR, Simmons NL, Hovav A-H, Letvin NL (2010) Efficient generation of mucosal and systemic antigen-specific CD8(+) T-cell responses following pulmonary DNA immunization. J Virol 84(11):5764\u20135774. doi:10.1128\/jvi.02202-09","journal-title":"J Virol"},{"issue":"1","key":"127_CR142","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/mi.2012.59","volume":"6","author":"M Bivas-Benita","year":"2013","unstructured":"Bivas-Benita M, Gillard GO, Bar L, White KA, Webby RJ, Hovav AH, Letvin NL (2013) Airway CD8(+) T cells induced by pulmonary DNA immunization mediate protective anti-viral immunity. Mucosal Immunol 6(1):156\u2013166. doi:10.1038\/mi.2012.59","journal-title":"Mucosal Immunol"},{"issue":"2","key":"127_CR143","doi-asserted-by":"publisher","first-page":"321","DOI":"10.4161\/hv.26796","volume":"10","author":"A Bolhassani","year":"2014","unstructured":"Bolhassani A, Javanzad S, Saleh T, Hashemi M, Aghasadeghi MR, Sadat SM (2014) Polymeric nanoparticles: potent vectors for vaccine delivery targeting cancer and infectious diseases. Human Vaccin Immunother 10(2):321\u2013332. doi:10.4161\/hv.26796","journal-title":"Human Vaccin Immunother"},{"key":"127_CR144","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jconrel.2016.05.010","volume":"234","author":"K Shiraishi","year":"2016","unstructured":"Shiraishi K, Kawano K, Maitani Y, Aoshi T, Ishii KJ, Sanada Y, Mochizuki S, Sakurai K, Yokoyama M (2016) Exploring the relationship between anti-PEG IgM behaviors and PEGylated nanoparticles and its significance for accelerated blood clearance. J Controlled Release 234:59\u201367. doi:10.1016\/j.jconrel.2016.05.010","journal-title":"J Controlled Release"},{"issue":"10","key":"127_CR145","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1007\/s11095-009-9943-x","volume":"26","author":"T Ishihara","year":"2009","unstructured":"Ishihara T, Takeda M, Sakamoto H, Kimoto A, Kobayashi C, Takasaki N, Yuki K, K-i Tanaka, Takenaga M, Igarashi R, Maeda T, Yamakawa N, Okamoto Y, Otsuka M, Ishida T, Kiwada H, Mizushima Y, Mizushima T (2009) Accelerated blood clearance phenomenon upon repeated injection of PEG-modified PLA-nanoparticles. Pharm Res 26(10):2270\u20132279. doi:10.1007\/s11095-009-9943-x","journal-title":"Pharm Res"},{"key":"127_CR146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/3-540-49424-3_1","volume":"146","author":"S Jacob","year":"1999","unstructured":"Jacob S, Kennedy JP (1999) Synthesis, characterization and properties of octa-arm polyisobutylene-based star polymers. Polym Synth Polym Polym Compl 146:1\u201338","journal-title":"Polym Synth Polym Polym Compl"},{"key":"127_CR147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/3-540-68310-0_1","volume":"142","author":"B Charleux","year":"1999","unstructured":"Charleux B, Faust R (1999) Synthesis of branched polymers by cationic polymerization. Branched Polym I 142:1\u201369","journal-title":"Branched Polym I"},{"key":"127_CR148","unstructured":"Pridgen EM, Alexis F, Langer RS, Farohkzad  OC (2009) Biodegradable, targeted nanoparticle drug delivery formulation for cancer therapy. Methods in bioengineering: nanoscale bioengineering and nanomedicine, pp 197\u2013222"},{"issue":"1\u20132","key":"127_CR149","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.taap.2010.04.014","volume":"246","author":"PC Naha","year":"2010","unstructured":"Naha PC, Davoren M, Lyng FM, Byrne HJ (2010) Reactive oxygen species (ROS) induced cytokine production and cytotoxicity of PAMAM dendrimers in J774A.1 cells. Toxicol Appl Pharmacol 246(1\u20132):91\u201399. doi:10.1016\/j.taap.2010.04.014","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"127_CR150","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/wnan.79","volume":"2","author":"DQ McNerny","year":"2010","unstructured":"McNerny DQ, Leroueil PR, Baker JR (2010) Understanding specific and nonspecific toxicities: a requirement for the development of dendrimer-based pharmaceuticals. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2(3):249\u2013259. doi:10.1002\/wnan.79","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"19","key":"127_CR151","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1016\/j.biomaterials.2007.03.006","volume":"28","author":"TH Chung","year":"2007","unstructured":"Chung TH, Wu SH, Yao M, Lu CW, Lin YS, Hung Y, Mou CY, Chen YC, Huang DM (2007) The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles 3T3-L1 cells and human mesenchymal stem cells. Biomaterials 28(19):2959\u20132966. doi:10.1016\/j.biomaterials.2007.03.006","journal-title":"Biomaterials"},{"issue":"3","key":"127_CR152","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1021\/nl803487r","volume":"9","author":"EC Cho","year":"2009","unstructured":"Cho EC, Xie JW, Wurm PA, Xia YN (2009) Understanding the role of surface charges in cellular adsorption versus internalization by selectively removing gold nanoparticles on the cell surface with a I-2\/KI etchant. Nano Lett 9(3):1080\u20131084. doi:10.1021\/nl803487r","journal-title":"Nano Lett"},{"key":"127_CR153","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jconrel.2016.06.017","volume":"235","author":"S Bhattacharjee","year":"2016","unstructured":"Bhattacharjee S (2016) DLS and zeta potential\u2014what they are and what they are not? J Controlled Release 235:337\u2013351. doi:10.1016\/j.jconrel.2016.06.017","journal-title":"J Controlled Release"},{"issue":"33","key":"127_CR154","doi-asserted-by":"publisher","first-page":"11613","DOI":"10.1073\/pnas.0801763105","volume":"105","author":"SEA Gratton","year":"2008","unstructured":"Gratton SEA, Ropp PA, Pohlhaus PD, Luft JC, Madden VJ, Napier ME, DeSimone JM (2008) The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci USA 105(33):11613\u201311618. doi:10.1073\/pnas.0801763105","journal-title":"Proc Natl Acad Sci USA"},{"key":"127_CR155","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.colsurfb.2014.10.003","volume":"123","author":"R Ferrari","year":"2014","unstructured":"Ferrari R, Lupi M, Colombo C, Morbidelli M, D\u2019Incalci M, Moscatelli D (2014) Investigation of size, surface charge, PEGylation degree and concentration on the cellular uptake of polymer nanoparticles. Colloid Surf B-Biointerfaces 123:639\u2013647. doi:10.1016\/j.colsurfb.2014.10.003","journal-title":"Colloid Surf B-Biointerfaces"},{"key":"127_CR156","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1042\/bj20031253","volume":"377","author":"J Rejman","year":"2004","unstructured":"Rejman J, Oberle V, Zuhorn IS, Hoekstra D (2004) Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis. Biochem J 377:159\u2013169. doi:10.1042\/bj20031253","journal-title":"Biochem J"},{"issue":"18","key":"127_CR157","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1016\/j.biomaterials.2007.02.021","volume":"28","author":"SK Lai","year":"2007","unstructured":"Lai SK, Hida K, Man ST, Chen C, Machamer C, Schroer TA, Hanes J (2007) Privileged delivery of polymer nanoparticles to the perinuclear region of live cells via a non-clathrin, non-degradative pathway. Biomaterials 28(18):2876\u20132884. doi:10.1016\/j.biomaterials.2007.02.021","journal-title":"Biomaterials"},{"issue":"5","key":"127_CR158","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1007\/s11095-010-0073-2","volume":"27","author":"V Filipe","year":"2010","unstructured":"Filipe V, Hawe A, Jiskoot W (2010) Critical evaluation of nanoparticle tracking analysis (NTA) by nanosight for the measurement of nanoparticles and protein aggregates. Pharm Res 27(5):796\u2013810. doi:10.1007\/s11095-010-0073-2","journal-title":"Pharm Res"},{"issue":"3","key":"127_CR159","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1208\/s12248-014-9579-6","volume":"16","author":"J Panchal","year":"2014","unstructured":"Panchal J, Kotarek J, Marszal E, Topp EM (2014) Analyzing subvisible particles in protein drug products: a comparison of dynamic light scattering (DLS) and resonant mass measurement (RMM). Aaps J 16(3):440\u2013451. doi:10.1208\/s12248-014-9579-6","journal-title":"Aaps J"},{"key":"127_CR160","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ab.2014.11.016","volume":"472","author":"C Zhou","year":"2015","unstructured":"Zhou C, Qi W, Lewis EN, Carpenter JF (2015) Concomitant Raman spectroscopy and dynamic light scattering for characterization of therapeutic proteins at high concentrations. Anal Biochem 472:7\u201320. doi:10.1016\/j.ab.2014.11.016","journal-title":"Anal Biochem"},{"issue":"14","key":"127_CR161","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1002\/smll.201102002","volume":"8","author":"L Florez","year":"2012","unstructured":"Florez L, Herrmann C, Cramer JM, Hauser CP, Koynov K, Landfester K, Crespy D, Mailander V (2012) How shape influences uptake: interactions of anisotropic polymer nanoparticles and human mesenchymal stem cells. Small 8(14):2222\u20132230. doi:10.1002\/smll.201102002","journal-title":"Small"},{"issue":"2","key":"127_CR162","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ejpb.2012.08.014","volume":"84","author":"C Troiber","year":"2013","unstructured":"Troiber C, Kasper JC, Milani S, Scheible M, Martin I, Schaubhut F, K\u00fcchler S, R\u00e4dler J, Simmel FC, Friess W, Wagner E (2013) Comparison of four different particle sizing methods for siRNA polyplex characterization. Eur J Pharm Biopharm 84(2):255\u2013264. doi:10.1016\/j.ejpb.2012.08.014","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"127_CR163","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1091\/mbc.E12-12-0863","volume":"25","author":"M Winey","year":"2014","unstructured":"Winey M, Meehl JB, O\u2019Toole ET, Giddings TH (2014) Conventional transmission electron microscopy. Mol Biol Cell 25(3):319\u2013323. doi:10.1091\/mbc.E12-12-0863","journal-title":"Mol Biol Cell"},{"key":"127_CR164","doi-asserted-by":"publisher","DOI":"10.1038\/srep25275","author":"C Hacker","year":"2016","unstructured":"Hacker C, Asadi J, Pliotas C, Ferguson S, Sherry L, Marius P, Tello J, Jackson D, Naismith J, Lucocq JM (2016) Nanoparticle suspensions enclosed in methylcellulose: a new approach for quantifying nanoparticles in transmission electron microscopy. Sci Rep. doi:10.1038\/srep25275","journal-title":"Sci Rep"},{"key":"127_CR165","doi-asserted-by":"publisher","unstructured":"Kratosova G, Dedkova K, Vavra I, Ciampor F (2014) Intracellular delivery II: fundamentals and applications. In: Prokop A, Iwasaki Y, Harada A (eds) Intracellular Delivery Ii: Fundamentals and applications, vol. 7. Fundamental Biomedical Technologies. Springer, Dordrecht, pp 1\u2013479. doi:10.1007\/978-94-017-8896-0","DOI":"10.1007\/978-94-017-8896-0"},{"issue":"8","key":"127_CR166","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nmat898","volume":"2","author":"AM Donald","year":"2003","unstructured":"Donald AM (2003) The use of environmental scanning electron microscopy for imaging wet and insulating materials. Nat Mater 2(8):511\u2013516. doi:10.1038\/nmat898","journal-title":"Nat Mater"},{"issue":"6","key":"127_CR167","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1088\/0957-4484\/23\/6\/062001","volume":"23","author":"T Ando","year":"2012","unstructured":"Ando T (2012) High-speed atomic force microscopy coming of age. Nanotechnology 23(6):27. doi:10.1088\/0957-4484\/23\/6\/062001","journal-title":"Nanotechnology"},{"issue":"8","key":"127_CR168","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1002\/adma.201404788","volume":"27","author":"J Sun","year":"2015","unstructured":"Sun J, Zhang L, Wang J, Feng Q, Liu D, Yin Q, Xu D, Wei Y, Ding B, Shi X, Jiang X (2015) Tunable Rigidity of (Polymeric Core)-(Lipid Shell) Nanoparticles for Regulated Cellular Uptake. Adv Mater 27(8):1402. doi:10.1002\/adma.201404788","journal-title":"Adv Mater"},{"issue":"3","key":"127_CR169","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1021\/acsnano.5b00147","volume":"9","author":"AC Anselmo","year":"2015","unstructured":"Anselmo AC, Zhang M, Kumar S, Vogus DR, Menegatti S, Helgeson ME, Mitragotri S (2015) Elasticity of nanopartides influences their blood circulation, phagocytosis, endocytosis, and targeting. ACS Nano 9(3):3169\u20133177. doi:10.1021\/acsnano.5b00147","journal-title":"ACS Nano"},{"issue":"46","key":"127_CR170","doi-asserted-by":"publisher","first-page":"16060","DOI":"10.1021\/la302706b","volume":"28","author":"ME Dokukin","year":"2012","unstructured":"Dokukin ME, Sokolov I (2012) Quantitative mapping of the elastic modulus of soft materials with harmonix and peakforce QNM AFM modes. Langmuir 28(46):16060\u201316071. doi:10.1021\/la302706b","journal-title":"Langmuir"}],"container-title":["Topics in Current Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41061-017-0127-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41061-017-0127-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41061-017-0127-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:06:28Z","timestamp":1744149988000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41061-017-0127-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,21]]},"references-count":170,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["127"],"URL":"https:\/\/doi.org\/10.1007\/s41061-017-0127-6","relation":{},"ISSN":["2365-0869","2364-8961"],"issn-type":[{"value":"2365-0869","type":"print"},{"value":"2364-8961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,21]]},"assertion":[{"value":"24 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"38"}}